NCT04421222 Oral EPI-7386 in Patients with Castration-Resistant Prostate Cancer Status TERMINATED Phase PHASE1
NCT04409288 Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer Status TERMINATED Phase PHASE3
NCT04404894 Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04403568 Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular Pathways in the Prostate Status WITHDRAWN Phase EARLY_PHASE1
NCT04402151 Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer Status RECRUITING Phase PHASE2
NCT04399876 Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer Status ENROLLING_BY_INVITATION Phase PHASE1
NCT04396808 Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT04393831 A Prospective Trial on Nerve Sparing Techniques Performed in Radical Prostatectomy Status TERMINATED Phase NA
NCT04390880 18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate Cancer Status COMPLETED Phase PHASE2
NCT04389918 Tolerability/Palatability of TalityTM Synthetic Meal Replacement in Prostate Cancer Status COMPLETED Phase NA
NCT04383210 Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors Status TERMINATED Phase PHASE2
NCT04382898 PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy) Status TERMINATED Phase PHASE1/PHASE2
NCT04377152 Expanded Access 68Gallium-PSMA-11 PET for Prostate Cancer Status APPROVED_FOR_MARKETING Phase N/A